EFFECTS OF CLOFIBRATE ON FIBRINOLYSIS, PLATELET STICKINESS, PLASMA-FIBRINOGEN, AND SERUM-CHOLESTEROL
- 9 November 1968
- journal article
- Published by Elsevier in The Lancet
- Vol. 292 (7576) , 1007-1009
- https://doi.org/10.1016/s0140-6736(68)91298-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- FIBRINOLYTIC ACTIVITY AND CORONARY-ARTERY DISEASEThe Lancet, 1968
- REDUCTION OF PLATELET STICKINESS BY PHENFORMIN PLUS ETHYLŒSTRENOLThe Lancet, 1967
- FIBRINOLYTIC TREATMENT OF RHEUMATOID ARTHRITIS WITH PHENFORMIN PLUS ETHYLŒSTRENOLThe Lancet, 1966
- Effects of clofibrate with androsterone (atromid) and without androsterone (atromid-S) on blood platelets and lipids in ischaemic heart disease.Heart, 1966
- FIBRINOLYTIC ACTIVITY RELATED TO AGE IN SURVIVORS OF MYOCARDIAL INFARCTIONThe Lancet, 1966
- Measurement of spontaneous fibrinolytic activityJournal of Clinical Pathology, 1964
- Pharmacological enhancement of fibrinolytic activity of bloodJournal of Clinical Pathology, 1964
- The Effect of Atromid on Plasma Fibrinogen and Heparin ResistanceJournal of Atherosclerosis Research, 1963
- Effect of atromid on platelet stickinessJournal of Atherosclerosis Research, 1963
- FIBRINOLYTIC ACTIVITY OF BLOODThe Lancet, 1963